Viracta Therapeutics Stock Quote VIRX - Stock Price, News, Charts, Message Board, Trades

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Premium

Current Price

0.2778

Bid

0.2498

Ask

0.31

Volume

497,371

0.2659 Day's Range 0.2999

0.2659 52 Week Range 1.5151

Market Cap

10.91M

Previous Close

0.289

Open

0.29

Last Trade

454

0.2778

(formt)

Last Trade Time

Financial Volume

$ 139,289

VWAP

0.280051

Average Volume (3m)

573,872

Shares Outstanding

39,272,434

Dividend Yield

PE Ratio

-0.22

Earnings Per Share (EPS)

-1.3

Revenue

Net Profit

-51.06M

Viracta Therapeutics Inc is a precision oncology company, focused on the development of new medicines targeting virus-associated malignancies. The company is conducting three clinical trials for its combination product candidate as a potential therapy for the treatment of relapsed/refractory Epstein... Viracta Therapeutics Inc is a precision oncology company, focused on the development of new medicines targeting virus-associated malignancies. The company is conducting three clinical trials for its combination product candidate as a potential therapy for the treatment of relapsed/refractory Epstein-Barr virus-positive lymphoma. Its lead product candidate is a combination product candidate consisting of nanatinostat, a potent and selective small molecule inhibitor of class I histone deacetylases (HDAC), and valganciclovir, an FDA-approved anti-viral drug used to treat and prevent disease caused by a virus called cytomegalovirus (CMV) in people who have received organ transplants. Show more

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.viracta.com

Headquarters

Wilmington, Delaware, USA

Founded

1970

Viracta Therapeutics Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker VIRX. The last closing price for Viracta Therapeutics was $0.29. Over the last year, Viracta Therapeutics shares have traded in a share price range of $ 0.2659 to $ 1.5151.

Viracta Therapeutics currently has 39,272,434 shares outstanding. The market capitalization of Viracta Therapeutics is $11.35 million. Viracta Therapeutics has a price to earnings ratio (PE ratio) of -0.22.

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 8-K - Current report

Viracta Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Update

- Reported combined Stage 1 and Stage 2 results from the relapsed or refractory EBV-positive peripheral T-cell lymphoma (PTCL) cohort of the Phase 2 NAVAL-1 trial demonstrating Nana-val’s...

Viracta Therapeutics Announces Positive Data from the Phase 2 NAVAL-1 Trial, Regulatory Progress, and Updated Nana-val Clinical Development Plan

- New combined Stage 1 and Stage 2 results from the relapsed or refractory EBV-positive peripheral T-cell lymphoma (PTCL) cohort of the Phase 2 NAVAL-1 trial further demonstrate Nana-val’s...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-0.0622	-18.2941176471	0.34	0.3499	0.2659	669587	0.29718516	CS
4	-0.2144	-43.5595286469	0.4922	0.56	0.2659	1413894	0.37379565	CS
12	-0.4032	-59.2070484581	0.681	0.8201	0.2659	573872	0.39818636	CS
26	-0.4522	-61.9452054795	0.73	1.31	0.2659	316746	0.48856637	CS
52	-1.0422	-78.9545454545	1.32	1.5151	0.2659	221572	0.53951715	CS
156	-9.0222	-97.0129032258	9.3	10.12	0.2659	199670	2.31244386	CS
260	-16.4822	-98.3424821002	16.76	18.24	0.2659	218162	4.07229714	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
PRTGPortage Biotech Inc	$ 5.90 (118.49%)	49.67M
MNTSMomentus Inc	$ 1.04 (80.65%)	231.74M
GHSIGuardion Health Sciences Inc	$ 17.91 (58.50%)	561.42k
RETOReTo Eco Solutions Inc	$ 1.591 (52.98%)	3.45M
HUBCWHub Cyber Security Ltd	$ 0.0149 (40.57%)	40.79k
UBXGU BX Technology Ltd	$ 2.38 (-92.54%)	35.79M
FAMIFarmmi Inc	$ 0.2336 (-58.76%)	14.1M
GDCGD Culture Group Ltd	$ 5.43 (-29.94%)	28.75M
NUWENewellis Inc	$ 1.26 (-26.74%)	754.69k
TGLTreasure Global Inc	$ 0.85 (-25.44%)	1.4M
NVDANVIDIA Corporation	$ 129.37 (4.55%)	323.15M
MNTSMomentus Inc	$ 1.04 (80.65%)	231.74M
SQQQProShares UltraPro Short QQQ	$ 7.98 (-3.16%)	186.3M
MULNMullen Automotive Inc	$ 0.3321 (-7.62%)	140.97M
APDNApplied DNA Sciences Inc	$ 2.4901 (36.07%)	127.34M